210 results on '"Coleman, Courtney"'
Search Results
2. An Electronic Health Record-integrated Web Application Augments a QI-directed Morbidity & Mortality Conference and Improves Quality of Care
- Author
-
Sajankila, Nitin, Javens, Thomas, Hampl, Josh, Coleman, Courtney, Murnane, Jami, Kenney, Brian D., and Besner, Gail E.
- Published
- 2024
- Full Text
- View/download PDF
3. European Respiratory Society Statement on preschool wheezing disorders: updated definitions, knowledge gaps, and proposed future research directions
- Author
-
Makrinioti, Heidi, primary, Fainardi, Valentina, additional, Bonnelykke, Klaus, additional, Custovic, Adnan, additional, Cicutto, Lisa, additional, Coleman, Courtney, additional, Eiwegger, Thomas, additional, Kuehni, Claudia, additional, Moeller, Alexander, additional, Pedersen, Eva, additional, Pijnenburg, Marielle, additional, Pinnock, Hilary, additional, Ranganathan, Sarath, additional, Tonia, Thomy, additional, Subbarao, Padmaja, additional, and Saglani, Sejal, additional
- Published
- 2024
- Full Text
- View/download PDF
4. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults
- Author
-
Bos, Saskia, primary, Murray, John, additional, Marchetti, Monia, additional, Cheng, Guang-Shing, additional, Bergeron, Anne, additional, Wolff, Daniel, additional, Sander, Clare, additional, Sharma, Akshay, additional, Badawy, Sherif M., additional, Peric, Zinaida, additional, Piekarska, Agnieszka, additional, Pidala, Joseph, additional, Raj, Kavita, additional, Penack, Olaf, additional, Kulkarni, Samar, additional, Beestrum, Molly, additional, Linke, Andrea, additional, Rutter, Matthew, additional, Coleman, Courtney, additional, Tonia, Thomy, additional, Schoemans, Hélène, additional, Stolz, Daiana, additional, and Vos, Robin, additional
- Published
- 2024
- Full Text
- View/download PDF
5. Patient-centred composite index for assessment of response to biological therapy for adult severe asthma.
- Author
-
Khaleva, Ekateirina, primary, Brightling, Chris, additional, Djukanovic, Ratko, additional, Dahlén, Sven-Erik, additional, Coleman, Courtney, additional, Henderson, Markaya, additional, and Roberts, Graham, additional
- Published
- 2023
- Full Text
- View/download PDF
6. European Respiratory Society short guidelines for the use of as-needed ICS/formoterol in mild asthma
- Author
-
Papi, Alberto, primary, Ferreira, Diogenes S., additional, Agache, Ioana, additional, Baraldi, Eugenio, additional, Beasley, Richard, additional, Brusselle, Guy, additional, Coleman, Courtney, additional, Gaga, Mina, additional, Gotera Rivera, Carolina Maria, additional, Melén, Erik, additional, Pavord, Ian D., additional, Peñate Gómez, Deborah, additional, Schuermans, Daniel, additional, Spanevello, Antonio, additional, Tonia, Thomy, additional, and Schleich, Florence, additional
- Published
- 2023
- Full Text
- View/download PDF
7. European Respiratory Society clinical practice guideline: palliative care for people with COPD or interstitial lung disease
- Author
-
Janssen, Daisy J.A., primary, Bajwah, Sabrina, additional, Boon, Michele Hilton, additional, Coleman, Courtney, additional, Currow, David C., additional, Devillers, Albert, additional, Vandendungen, Chantal, additional, Ekström, Magnus, additional, Flewett, Ron, additional, Greenley, Sarah, additional, Guldin, Mai-Britt, additional, Jácome, Cristina, additional, Johnson, Miriam J., additional, Kurita, Geana Paula, additional, Maddocks, Matthew, additional, Marques, Alda, additional, Pinnock, Hilary, additional, Simon, Steffen T., additional, Tonia, Thomy, additional, and Marsaa, Kristoffer, additional
- Published
- 2023
- Full Text
- View/download PDF
8. Patients’ acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: a cicero CRC - ELF online patient survey
- Author
-
Gyselinck, Iwein, primary, Ramakrishnan, Sanjay, additional, Vermeersch, Kristina, additional, Halner, Andreas, additional, Pott, Hendrik, additional, Dobbels, Fabienne, additional, Coleman, Courtney, additional, Collis, Philip, additional, Watz, Henrik, additional, Greulich, Timm, additional, Franssen, Frits M.E., additional, Burgel, Pierre-Régis, additional, Bafadhel, Mona, additional, and Janssens, Wim, additional
- Published
- 2023
- Full Text
- View/download PDF
9. European Respiratory Society Clinical Practice Guideline:Palliative care for people with chronic obstructive pulmonary disease or interstitial lung disease
- Author
-
Janssen, Daisy J A, Bajwah, Sabrina, Boon, Michele Hilton, Coleman, Courtney, Currow, David C, Devillers, Albert, Vandendungen, Chantal, Ekström, Magnus, Flewett, Ron, Greenley, Sarah, Guldin, Mai-Britt, Jácome, Cristina, Johnson, Miriam J, Kurita, Geana Paula, Maddocks, Matthew, Marques, Alda, Pinnock, Hilary, Simon, Steffen T, Tonia, Thomy, and Marsaa, Kristoffer
- Abstract
There is increased awareness of palliative care needs in people with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD). This European Respiratory Society (ERS) task force aimed to provide recommendations for initiation and integration of palliative care into the respiratory care of adult people with COPD or ILD.The ERS task force consisted of 20 members, including representatives of people with COPD or ILD and informal caregivers. Eight questions were formulated, four in the 'Population, Intervention, Comparison, Outcome' (PICO) format. These were addressed with full systematic reviews and application of Grading of Recommendations Assessment, Development and Evaluation (GRADE) for assessing the evidence. Four additional questions were addressed narratively. An 'evidence-to-decision' framework was used to formulate recommendations.The following definition of palliative care for people with COPD or ILD was agreed: A holistic and multidisciplinary, person-centred approach aiming to control symptoms, and improve quality of life of people with serious health-related suffering because of COPD or ILD, and to support their informal caregivers. Recommendations were made regarding people with COPD or ILD and their informal caregivers to: consider palliative care when physical, psychological, social, or existential needs are identified through holistic needs assessment; offer palliative care interventions, including support for informal caregivers, in accordance with such needs; offer advance care planning in accordance with preferences; and integrate palliative care into routine COPD and ILD care. Recommendations should be reconsidered as new evidence becomes available.
- Published
- 2023
10. Core outcome sets, developed collaboratively with patients, can improve the relevance and comparability of clinical trials
- Author
-
Mathioudakis, Alexander G., primary, Khaleva, Ekaterina, additional, Fally, Markus, additional, Williamson, Paula R., additional, Jensen, Jens-Ulrik, additional, Felton, Tim W., additional, Brightling, Chris, additional, Bush, Andrew, additional, Winders, Tonya, additional, Linnell, John, additional, Ramiconi, Valeria, additional, Coleman, Courtney, additional, Welte, Tobias, additional, Roberts, Graham, additional, and Vestbo, Jørgen, additional
- Published
- 2023
- Full Text
- View/download PDF
11. What bothers severe asthma patients most? A paired patient-clinician study across seven European countries
- Author
-
Ainsworth, Ben, primary, Chatburn, Eleanor, additional, Bansal, Aruna T, additional, Fulton, Olivia, additional, Hamerlijnck, Dominique, additional, Coleman, Courtney, additional, Eger, Katrien, additional, Hyland, Michael, additional, Holmes, Joshua, additional, Heaney, Liam, additional, Sedlák, Vratislav, additional, Škrgat, Sabina, additional, Edelbaher, Natalija, additional, ten Brinke, Anneke, additional, Porsbjerg, Celeste, additional, Gaga, Mina, additional, Loureiro, Claudia, additional, Djukanovic, Ratko, additional, Berret, Emmanuelle, additional, and Kwon, Namhee, additional
- Published
- 2023
- Full Text
- View/download PDF
12. Principles of patient partnership: integrating patient perspectives into ERS Clinical Research Collaborations
- Author
-
Coleman, Courtney, primary, Fulton, Olivia, additional, Boyd, Jeanette, additional, Williams, Clare, additional, Powell, Zena, additional, Brightling, Christopher E., additional, van den Berge, Maarten, additional, Siddiqui, Salman, additional, and Powell, Pippa, additional
- Published
- 2023
- Full Text
- View/download PDF
13. Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)
- Author
-
Khaleva, Ekaterina, Rattu, Anna, Brightling, Chris, Bush, Andrew, Bossios, Apostolos, Bourdin, Arnaud, Chung, Kian Fan, Chaudhuri, Rekha, Coleman, Courtney, Dahlén, Sven Erik, Djukanovic, Ratko, Deschildre, Antoine, Fleming, Louise, Fowler, Stephen J., Gupta, Atul, Hamelmann, Eckard, Hashimoto, Simone, Hedlin, Gunilla, Koppelman, Gerard H., Melén, Erik, Murray, Clare S., Pilette, Charles, Porsbjerg, Celeste, Pike, Katharine C., Rusconi, Franca, Williams, Clare, Ahrens, Birgit, Alter, Peter, Anckers, Freja, van den Berge, Maarten, Blumchen, Katharina, Brusselle, Guy, Clarke, Graham W., Cunoosamy, Danen, Dahlén, Barbro, Dixey, Piers, Exley, Andrew, Frey, Urs, Gaillard, Erol A., Giovannini-Chami, Lisa, Grigg, Jonathan, Hartenstein, Diana, Heaney, Liam G., Karadag, Bülent, Kaul, Susanne, Kull, Inger, Licari, Amelia, Maitland-van der Zee, Anke-Hilse, Mahler, Vera, Schoos, Ann Marie M., Nagakumar, Prasad, Negus, Jenny, Nielsen, Hanna, Pijnenburg, Mariëlle, Ramiconi, Valeria, Romagosa Vilarnau, Sofia, Principe, Stefania, Rutjes, Niels W. P., Saglani, Sejal, Seddon, Paul C, Singer, Florian, Staudinger, Heribert, Turner, Steve, Vijverberg, Susanne J, Winders, Tonya, Yasinska, Valentyna, Roberts, Graham, Sverrild, Asger, Lapperre, Therese, Khaleva, Ekaterina, Rattu, Anna, Brightling, Chris, Bush, Andrew, Bossios, Apostolos, Bourdin, Arnaud, Chung, Kian Fan, Chaudhuri, Rekha, Coleman, Courtney, Dahlén, Sven Erik, Djukanovic, Ratko, Deschildre, Antoine, Fleming, Louise, Fowler, Stephen J., Gupta, Atul, Hamelmann, Eckard, Hashimoto, Simone, Hedlin, Gunilla, Koppelman, Gerard H., Melén, Erik, Murray, Clare S., Pilette, Charles, Porsbjerg, Celeste, Pike, Katharine C., Rusconi, Franca, Williams, Clare, Ahrens, Birgit, Alter, Peter, Anckers, Freja, van den Berge, Maarten, Blumchen, Katharina, Brusselle, Guy, Clarke, Graham W., Cunoosamy, Danen, Dahlén, Barbro, Dixey, Piers, Exley, Andrew, Frey, Urs, Gaillard, Erol A., Giovannini-Chami, Lisa, Grigg, Jonathan, Hartenstein, Diana, Heaney, Liam G., Karadag, Bülent, Kaul, Susanne, Kull, Inger, Licari, Amelia, Maitland-van der Zee, Anke-Hilse, Mahler, Vera, Schoos, Ann Marie M., Nagakumar, Prasad, Negus, Jenny, Nielsen, Hanna, Pijnenburg, Mariëlle, Ramiconi, Valeria, Romagosa Vilarnau, Sofia, Principe, Stefania, Rutjes, Niels W. P., Saglani, Sejal, Seddon, Paul C, Singer, Florian, Staudinger, Heribert, Turner, Steve, Vijverberg, Susanne J, Winders, Tonya, Yasinska, Valentyna, Roberts, Graham, Sverrild, Asger, and Lapperre, Therese
- Abstract
Background Effectiveness studies with biological therapies for asthma lack standardised outcome measures. The COMSA (Core Outcome Measures sets for paediatric and adult Severe Asthma) Working Group sought to develop Core Outcome Measures (COM) sets to facilitate better synthesis of data and appraisal of biologics in paediatric and adult asthma clinical studies. Methods COMSA utilised a multi-stakeholder consensus process among patients with severe asthma, adult and paediatric clinicians, pharmaceutical representatives, and health regulators from across Europe. Evidence included a systematic review of development, validity and reliability of selected outcome measures plus a narrative review and a pan-European survey to better understand patients’ and carers’ views about outcome measures. It was discussed using a modified GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision framework. Anonymous voting was conducted using predefined consensus criteria. Results Both adult and paediatric COM sets include forced expiratory volume in 1 s (FEV1) as z-scores, annual frequency of severe exacerbations and maintenance oral corticosteroid use. Additionally, the paediatric COM set includes the Paediatric Asthma Quality of Life Questionnaire and Asthma Control Test or Childhood Asthma Control Test, while the adult COM set includes the Severe Asthma Questionnaire and Asthma Control Questionnaire-6 (symptoms and rescue medication use reported separately). Conclusions This patient-centred collaboration has produced two COM sets for paediatric and adult severe asthma. It is expected that they will inform the methodology of future clinical trials, enhance comparability of efficacy and effectiveness of biological therapies, and help assess their socioeconomic value. COMSA will inform definitions of non-response and response to biological therapy for severe asthma., Background Effectiveness studies with biological therapies for asthma lack standardised outcome measures. The COMSA (Core Outcome Measures sets for paediatric and adult Severe Asthma) Working Group sought to develop Core Outcome Measures (COM) sets to facilitate better synthesis of data and appraisal of biologics in paediatric and adult asthma clinical studies. Methods COMSA utilised a multi-stakeholder consensus process among patients with severe asthma, adult and paediatric clinicians, pharmaceutical representatives, and health regulators from across Europe. Evidence included a systematic review of development, validity and reliability of selected outcome measures plus a narrative review and a pan-European survey to better understand patients’ and carers’ views about outcome measures. It was discussed using a modified GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision framework. Anonymous voting was conducted using predefined consensus criteria. Results Both adult and paediatric COM sets include forced expiratory volume in 1 s (FEV1) as z-scores, annual frequency of severe exacerbations and maintenance oral corticosteroid use. Additionally, the paediatric COM set includes the Paediatric Asthma Quality of Life Questionnaire and Asthma Control Test or Childhood Asthma Control Test, while the adult COM set includes the Severe Asthma Questionnaire and Asthma Control Questionnaire-6 (symptoms and rescue medication use reported separately). Conclusions This patient-centred collaboration has produced two COM sets for paediatric and adult severe asthma. It is expected that they will inform the methodology of future clinical trials, enhance comparability of efficacy and effectiveness of biological therapies, and help assess their socioeconomic value. COMSA will inform definitions of non-response and response to biological therapy for severe asthma.
- Published
- 2023
14. What bothers severe asthma patients most? A paired patient–clinician study across seven European countries
- Author
-
Ainsworth, Ben, Chatburn, Eleanor, Bansal, Aruna T., Fulton, Olivia, Hamerlijnck, Dominique, Coleman, Courtney, Eger, Katrien, Hyland, Michael, Holmes, Joshua, Heaney, Liam, Sedlák, Vratislav, Škrgat, Sabina, Edelbaher, Natalija, Brinke, Anneke Ten, Porsbjerg, Celeste, Gaga, Mina, Loureiro, Claudia, Djukanovic, Ratko, Berret, Emmanuelle, Kwon, Namhee, Ainsworth, Ben, Chatburn, Eleanor, Bansal, Aruna T., Fulton, Olivia, Hamerlijnck, Dominique, Coleman, Courtney, Eger, Katrien, Hyland, Michael, Holmes, Joshua, Heaney, Liam, Sedlák, Vratislav, Škrgat, Sabina, Edelbaher, Natalija, Brinke, Anneke Ten, Porsbjerg, Celeste, Gaga, Mina, Loureiro, Claudia, Djukanovic, Ratko, Berret, Emmanuelle, and Kwon, Namhee
- Abstract
Introduction Severe asthma is a complex, multidimensional disease. Optimal treatment, adherence and outcomes require shared decision-making, rooted in mutual understanding between patient and clinician. This study used a novel, patient-centred approach to examine the most bothersome aspects of severe asthma to patients, as seen from both perspectives in asthma registries. Methods Across seven countries, 126 patients with severe asthma completed an open-ended survey regarding most the bothersome aspect(s) of their asthma. Patients’ responses were linked with their treating clinician who also completed a free-text survey about each patient's most bothersome aspect(s). Responses were coded using content analysis, and patient and clinician responses were compared. Finally, asthma registries that are part of the SHARP (Severe Heterogeneous Asthma Research collaboration, Patient-centred) Clinical Research Collaboration were examined to see the extent to which they reflected the most bothersome aspects reported by patients. Results 88 codes and 10 themes were identified. Clinicians were more focused on direct physical symptoms and were less focused on “holistic” aspects such as the effort required to self-manage the disease. Clinicians accurately identified a most bothersome symptom for 29% of patients. Agreement was particularly low with younger patients and those using oral corticosteroids infrequently. In asthma registries, patient aspects were predominantly represented in questionnaires. Conclusions Results demonstrated different perspectives and priorities between patients and clinicians, with clinicians more focused on physical aspects. These differences must be considered when treating individual patients, and within multidisciplinary treatment teams. The use of questionnaires that include multifaceted aspects of disease may result in improved asthma research., Introduction Severe asthma is a complex, multidimensional disease. Optimal treatment, adherence and outcomes require shared decision-making, rooted in mutual understanding between patient and clinician. This study used a novel, patient-centred approach to examine the most bothersome aspects of severe asthma to patients, as seen from both perspectives in asthma registries. Methods Across seven countries, 126 patients with severe asthma completed an open-ended survey regarding most the bothersome aspect(s) of their asthma. Patients’ responses were linked with their treating clinician who also completed a free-text survey about each patient’s most bothersome aspect(s). Responses were coded using content analysis, and patient and clinician responses were compared. Finally, asthma registries that are part of the SHARP (Severe Heterogeneous Asthma Research collaboration, Patient-centred) Clinical Research Collaboration were examined to see the extent to which they reflected the most bothersome aspects reported by patients. Results 88 codes and 10 themes were identified. Clinicians were more focused on direct physical symptoms and were less focused on “holistic” aspects such as the effort required to self-manage the disease. Clinicians accurately identified a most bothersome symptom for 29% of patients. Agreement was particularly low with younger patients and those using oral corticosteroids infrequently. In asthma registries, patient aspects were predominantly represented in questionnaires. Conclusions Results demonstrated different perspectives and priorities between patients and clinicians, with clinicians more focused on physical aspects. These differences must be considered when treating individual patients, and within multidisciplinary treatment teams. The use of questionnaires that include multifaceted aspects of disease may result in improved asthma research.
- Published
- 2023
15. Patients’ acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: A CICERO clinical research collaboration–European lung foundation online patient survey
- Author
-
Gyselinck, Iwein, Ramakrishnan, Sanjay, Vermeersch, Kristina, Halner, Andreas, Pott, Hendrik, Dobbels, Fabienne, Coleman, Courtney, Collis, Philip, Watz, Henrik, Greulich, Timm, Franssen, Frits M. E., Burgel, Pierre-Régis, Bafadhel, Mona, Janssens, Wim, CICERO Consortium, Gyselinck, Iwein, Ramakrishnan, Sanjay, Vermeersch, Kristina, Halner, Andreas, Pott, Hendrik, Dobbels, Fabienne, Coleman, Courtney, Collis, Philip, Watz, Henrik, Greulich, Timm, Franssen, Frits M. E., Burgel, Pierre-Régis, Bafadhel, Mona, Janssens, Wim, and CICERO Consortium
- Abstract
Background: The lack of standardised outcome assessments during hospitalisation and follow-up for acute COPD exacerbations has hampered scientific progress and clinical proficiency. The objective of the present study was to evaluate patients’ acceptance of selected outcome and experience measurements during hospitalisations for COPD exacerbations and follow-up. Methods: An online survey was held amongst COPD patients in France, Belgium, The Netherlands, Germany and the UK. The European Lung Foundation COPD Patient Advisory Group was involved in the conceptualisation, development and dissemination of the survey. The survey was complementary to a previously obtained expert consensus. We assessed patients’ views and acceptance of selected patient-reported outcomes or experiences and corresponding measurement instruments (for dyspnoea, frequent productive cough, health status and hospitalisation experience), and of selected clinical investigations (blood draw, pulmonary function test, 6-min walk test, chest computed tomography, echocardiography). Findings: 200 patients completed the survey. All selected outcomes and experiences were deemed important, and acceptance of their methods of assessment was high. The modified Medical Research Council scale and a numerical rating scale to address dyspnoea, the COPD Assessment Test for quality of life and frequent productive cough, and the Hospital Consumer Assessment of Healthcare Providers and Systems for hospital experiences were the instruments preferred by patients. Consensus on importance of blood draw and spirometry was higher compared with the other investigations. Interpretation: The survey results endorse the use of the selected outcome and experience measurements during hospitalisations for COPD exacerbations. They can be used to optimise standardised and patient-centred care and facilitate multicentric data collection.
- Published
- 2023
16. Core outcome sets, developed collaboratively with patients, can improve the relevance and comparability of clinical trials
- Author
-
Mathioudakis, Alexander G., Khaleva, Ekaterina, Fally, Markus, Williamson, Paula R., Jensen, Jens Ulrik, Felton, Tim W., Brightling, Chris, Bush, Andrew, Winders, Tonya, Linnell, John, Ramiconi, Valeria, Coleman, Courtney, Welte, Tobias, Roberts, Graham, Vestbo, Jørgen, Mathioudakis, Alexander G., Khaleva, Ekaterina, Fally, Markus, Williamson, Paula R., Jensen, Jens Ulrik, Felton, Tim W., Brightling, Chris, Bush, Andrew, Winders, Tonya, Linnell, John, Ramiconi, Valeria, Coleman, Courtney, Welte, Tobias, Roberts, Graham, and Vestbo, Jørgen
- Published
- 2023
17. European Respiratory Society clinical practice guideline:palliative care for people with COPD or interstitial lung disease
- Author
-
Janssen, Daisy J A, Bajwah, Sabrina, Boon, Michele Hilton, Coleman, Courtney, Currow, David C, Devillers, Albert, Vandendungen, Chantal, Ekström, Magnus, Flewett, Ron, Greenley, Sarah, Guldin, Mai-Britt, Jácome, Cristina, Johnson, Miriam J, Kurita, Geana Paula, Maddocks, Matthew, Marques, Alda, Pinnock, Hilary, Simon, Steffen T, Tonia, Thomy, Marsaa, Kristoffer, Janssen, Daisy J A, Bajwah, Sabrina, Boon, Michele Hilton, Coleman, Courtney, Currow, David C, Devillers, Albert, Vandendungen, Chantal, Ekström, Magnus, Flewett, Ron, Greenley, Sarah, Guldin, Mai-Britt, Jácome, Cristina, Johnson, Miriam J, Kurita, Geana Paula, Maddocks, Matthew, Marques, Alda, Pinnock, Hilary, Simon, Steffen T, Tonia, Thomy, and Marsaa, Kristoffer
- Abstract
There is increased awareness of palliative care needs in people with COPD or interstitial lung disease (ILD). This European Respiratory Society (ERS) task force aimed to provide recommendations for initiation and integration of palliative care into the respiratory care of adult people with COPD or ILD. The ERS task force consisted of 20 members, including representatives of people with COPD or ILD and informal caregivers. Eight questions were formulated, four in the Population, Intervention, Comparison, Outcome format. These were addressed with full systematic reviews and application of Grading of Recommendations Assessment, Development and Evaluation for assessing the evidence. Four additional questions were addressed narratively. An “evidence-to-decision” framework was used to formulate recommendations. The following definition of palliative care for people with COPD or ILD was agreed. A holistic and multidisciplinary person-centred approach aiming to control symptoms and improve quality of life of people with serious health-related suffering because of COPD or ILD, and to support their informal caregivers. Recommendations were made regarding people with COPD or ILD and their informal caregivers: to consider palliative care when physical, psychological, social or existential needs are identified through holistic needs assessment; to offer palliative care interventions, including support for informal caregivers, in accordance with such needs; to offer advance care planning in accordance with preferences; and to integrate palliative care into routine COPD and ILD care. Recommendations should be reconsidered as new evidence becomes available., There is increased awareness of palliative care needs in people with COPD or interstitial lung disease (ILD). This European Respiratory Society (ERS) task force aimed to provide recommendations for initiation and integration of palliative care into the respiratory care of adult people with COPD or ILD. The ERS task force consisted of 20 members, including representatives of people with COPD or ILD and informal caregivers. Eight questions were formulated, four in the Population, Intervention, Comparison, Outcome format. These were addressed with full systematic reviews and application of Grading of Recommendations Assessment, Development and Evaluation for assessing the evidence. Four additional questions were addressed narratively. An "evidence-to-decision" framework was used to formulate recommendations. The following definition of palliative care for people with COPD or ILD was agreed. A holistic and multidisciplinary person-centred approach aiming to control symptoms and improve quality of life of people with serious health-related suffering because of COPD or ILD, and to support their informal caregivers. Recommendations were made regarding people with COPD or ILD and their informal caregivers: to consider palliative care when physical, psychological, social or existential needs are identified through holistic needs assessment; to offer palliative care interventions, including support for informal caregivers, in accordance with such needs; to offer advance care planning in accordance with preferences; and to integrate palliative care into routine COPD and ILD care. Recommendations should be reconsidered as new evidence becomes available.
- Published
- 2023
18. Definitions of non-response and response to biological therapy for severe asthma: a systematic review
- Author
-
Khaleva, Ekaterina, primary, Rattu, Anna, additional, Brightling, Chris, additional, Bush, Andrew, additional, Bourdin, Arnaud, additional, Bossios, Apostolos, additional, Chung, Kian Fan, additional, Chaudhuri, Rekha, additional, Coleman, Courtney, additional, Djukanovic, Ratko, additional, Dahlén, Sven-Erik, additional, Exley, Andrew, additional, Fleming, Louise, additional, Fowler, Stephen J., additional, Gupta, Atul, additional, Hamelmann, Eckard, additional, Koppelman, Gerard H., additional, Melén, Erik, additional, Mahler, Vera, additional, Seddon, Paul, additional, Singer, Florian, additional, Porsbjerg, Celeste, additional, Ramiconi, Valeria, additional, Rusconi, Franca, additional, Yasinska, Valentyna, additional, and Roberts, Graham, additional
- Published
- 2023
- Full Text
- View/download PDF
19. Identifying and appraising outcome measures for severe asthma: a systematic review
- Author
-
Rattu, Anna, primary, Khaleva, Ekaterina, additional, Brightling, Chris, additional, Dahlén, Sven-Erik, additional, Bossios, Apostolos, additional, Fleming, Louise, additional, Chung, Kian Fan, additional, Melén, Erik, additional, Djukanovic, Ratko, additional, Chaudhuri, Rekha, additional, Exley, Andrew, additional, Koppelman, Gerard H., additional, Bourdin, Arnaud, additional, Rusconi, Franca, additional, Porsbjerg, Celeste, additional, Coleman, Courtney, additional, Williams, Clare, additional, Nielsen, Hanna, additional, Davin, Elizabeth, additional, Taverner, Phil, additional, Romagosa Vilarnau, Sofia, additional, and Roberts, Graham, additional
- Published
- 2022
- Full Text
- View/download PDF
20. European Respiratory Society Clinical Practice Guideline: Palliative care for people with chronic obstructive pulmonary disease or interstitial lung disease
- Author
-
Janssen, Daisy J A, Bajwah, Sabrina, Boon, Michele Hilton, Coleman, Courtney, Currow, David C, Devillers, Albert, Vandendungen, Chantal, Ekström, Magnus, Flewett, Ron, Greenley, Sarah, Guldin, Mai-Britt, Jácome, Cristina, Johnson, Miriam J, Kurita, Geana Paula, Maddocks, Matthew, Marques, Alda, Pinnock, Hilary, Simon, Steffen T, Tonia, Thomy, and Marsaa, Kristoffer
- Subjects
610 Medicine & health ,360 Social problems & social services - Abstract
There is increased awareness of palliative care needs in people with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD). This European Respiratory Society (ERS) task force aimed to provide recommendations for initiation and integration of palliative care into the respiratory care of adult people with COPD or ILD.The ERS task force consisted of 20 members, including representatives of people with COPD or ILD and informal caregivers. Eight questions were formulated, four in the 'Population, Intervention, Comparison, Outcome' (PICO) format. These were addressed with full systematic reviews and application of Grading of Recommendations Assessment, Development and Evaluation (GRADE) for assessing the evidence. Four additional questions were addressed narratively. An 'evidence-to-decision' framework was used to formulate recommendations.The following definition of palliative care for people with COPD or ILD was agreed: A holistic and multidisciplinary, person-centred approach aiming to control symptoms, and improve quality of life of people with serious health-related suffering because of COPD or ILD, and to support their informal caregivers. Recommendations were made regarding people with COPD or ILD and their informal caregivers to: consider palliative care when physical, psychological, social, or existential needs are identified through holistic needs assessment; offer palliative care interventions, including support for informal caregivers, in accordance with such needs; offer advance care planning in accordance with preferences; and integrate palliative care into routine COPD and ILD care. Recommendations should be reconsidered as new evidence becomes available.
- Published
- 2023
- Full Text
- View/download PDF
21. Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)
- Author
-
Khaleva, Ekaterina, Rattu, Anna, Brightling, Chris, Bush, Andrew, Bossios, Apostolos, Bourdin, Arnaud, Chung, Kian Fan, Chaudhuri, Rekha, Coleman, Courtney, Dahlén, Sven-Erik, Djukanovic, Ratko, Deschildre, Antoine, Fleming, Louise, Fowler, Stephen J, Gupta, Atul, Hamelmann, Eckard, Hashimoto, Simone, Hedlin, Gunilla, Koppelman, Gerard H, Melén, Erik, Murray, Clare S, Pilette, Charles, Porsbjerg, Celeste, Pike, Katharine C, Rusconi, Franca, Williams, Clare, Ahrens, Birgit, Alter, Peter, Anckers, Freja, van den Berge, Maarten, Blumchen, Katharina, Brusselle, Guy, Clarke, Graham W, Cunoosamy, Danen, Dahlén, Barbro, Dixey, Piers, Exley, Andrew, Frey, Urs, Gaillard, Erol A, Giovannini-Chami, Lisa, Grigg, Jonathan, Hartenstein, Diana, Heaney, Liam G, Karadag, Bülent, Kaul, Susanne, Kull, Inger, Licari, Amelia, Maitland-van der Zee, Anke H, Mahler, Vera, and Roberts, Graham
- Abstract
BACKGROUND: Effectiveness studies with biological therapies for asthma lack standardised outcome measures. The COMSA (Core Outcome Measures sets for paediatric and adult Severe Asthma) working group sought to develop Core Outcome Measures (COM) sets to facilitate better synthesis of data and appraisal of biologics in paediatric and adult asthma clinical studies.METHODS: COMSA utilised a multi-stakeholder consensus process among patients with severe asthma, adult, and paediatric clinicians, pharmaceutical representatives and health regulators from across Europe. Evidence included a systematic review of development, validity, and reliability of selected outcome measures plus a narrative review and a pan-European survey to better understand patients' and carers' views about outcome measures. It was discussed using a modified GRADE Evidence to Decision framework. Anonymous voting was conducted using predefined consensus criteria.RESULTS: Both adult and paediatric COM sets include forced expiratory volume in 1 s (FEV1) as z scores, annual frequency of severe exacerbations and maintenance oral corticosteroid use. Additionally, the paediatric COM set includes the Paediatric Asthma Quality of Life Questionnaire, and Asthma Control Test (ACT) or Childhood-ACT while the adult COM includes the Severe Asthma Questionnaire and the Asthma Control Questionnaire-6 (symptoms and rescue medication use reported separately).CONCLUSIONS: This patient-centred collaboration has produced two COM sets for paediatric and adult severe asthma. It is expected that they will inform the methodology of future clinical trials, enhance comparability of efficacy and effectiveness of biological therapies, and help assess their socioeconomic value. COMSA will inform definitions of non-response and response to biological therapy for severe asthma.
- Published
- 2022
22. Use of Quality Improvement–Directed Morbidity and Mortality Conference and an Electronic Database to Analyze Trends in System Failures
- Author
-
Sajankila, Nitin, primary, Javens, Tom, additional, Coleman, Courtney, additional, Kenney, Brian D, additional, and Besner, Gail E, additional
- Published
- 2022
- Full Text
- View/download PDF
23. Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)
- Author
-
Khaleva, Ekaterina, primary, Rattu, Anna, additional, Brightling, Chris, additional, Bush, Andrew, additional, Bossios, Apostolos, additional, Bourdin, Arnaud, additional, Chung, Kian Fan, additional, Chaudhuri, Rekha, additional, Coleman, Courtney, additional, Dahlén, Sven-Erik, additional, Djukanovic, Ratko, additional, Deschildre, Antoine, additional, Fleming, Louise, additional, Fowler, Stephen J., additional, Gupta, Atul, additional, Hamelmann, Eckard, additional, Hashimoto, Simone, additional, Hedlin, Gunilla, additional, Koppelman, Gerard H., additional, Melén, Erik, additional, Murray, Clare S., additional, Pilette, Charles, additional, Porsbjerg, Celeste, additional, Pike, Katharine C., additional, Rusconi, Franca, additional, Williams, Clare, additional, Ahrens, Birgit, additional, Alter, Peter, additional, Anckers, Freja, additional, van den Berge, Maarten, additional, Blumchen, Katharina, additional, Brusselle, Guy, additional, Clarke, Graham W., additional, Cunoosamy, Danen, additional, Dahlén, Barbro, additional, Dixey, Piers, additional, Exley, Andrew, additional, Frey, Urs, additional, Gaillard, Erol A., additional, Giovannini-Chami, Lisa, additional, Grigg, Jonathan, additional, Hartenstein, Diana, additional, Heaney, Liam G., additional, Karadag, Bülent, additional, Kaul, Susanne, additional, Kull, Inger, additional, Licari, Amelia, additional, Maitland-van der Zee, Anke H., additional, Mahler, Vera, additional, Schoos, Ann-Marie M., additional, Nagakumar, Prasad, additional, Negus, Jenny, additional, Nielsen, Hanna, additional, Paton, James, additional, Pijnenburg, Mariëlle, additional, Ramiconi, Valeria, additional, Romagosa Vilarnau, Sofia, additional, Principe, Stefania, additional, Rutjes, Niels, additional, Saglani, Sejal, additional, Seddon, Paul, additional, Singer, Florian, additional, Staudinger, Heribert, additional, Turner, Steve, additional, Vijverberg, Susanne, additional, Winders, Tonya, additional, Yasinska, Valentyna, additional, and Roberts, Graham, additional
- Published
- 2022
- Full Text
- View/download PDF
24. Narrative review to capture patients’ perceptions and opinions about non-response and response to biological therapy for severe asthma
- Author
-
Coleman, Courtney, primary, Khaleva, Ekaterina, additional, Rattu, Anna, additional, Frankemölle, Betty, additional, Nielsen, Hanna, additional, Roberts, Graham, additional, and Williams, Clare, additional
- Published
- 2022
- Full Text
- View/download PDF
25. InDel markers for monitoring the introgression of downy mildew resistance from wild relatives into grape varieties
- Author
-
Foria, Serena, Magris, Gabriele, Copetti, Dario, Coleman, Courtney, Morgante, Michele, and Di Gaspero, Gabriele
- Published
- 2018
- Full Text
- View/download PDF
26. European Respiratory Society guidelines for the diagnosis of asthma in adults
- Author
-
Louis, Renaud, Satia, Imran, Ojanguren, Inigo, Schleich, Florence, Bonini, Matteo, Tonia, Thomy, Rigau, David, Brinke, Anne ten, Buhl, Roland, Loukides, Stelios, Kocks, Janwillem W. H., Boulet, Louis-Philippe, Bourdin, Arnaud, Coleman, Courtney, Needham, Karen, Thomas, Mike, Idzko, Marco, Papi, Alberto, Porsbjerg, Celeste, Schuermans, Daniel, Soriano, Joan B., Usmani, Omar S., Louis, Renaud, Satia, Imran, Ojanguren, Inigo, Schleich, Florence, Bonini, Matteo, Tonia, Thomy, Rigau, David, Brinke, Anne ten, Buhl, Roland, Loukides, Stelios, Kocks, Janwillem W. H., Boulet, Louis-Philippe, Bourdin, Arnaud, Coleman, Courtney, Needham, Karen, Thomas, Mike, Idzko, Marco, Papi, Alberto, Porsbjerg, Celeste, Schuermans, Daniel, Soriano, Joan B., and Usmani, Omar S.
- Abstract
Although asthma is very common, affecting 5-10% of the population, the diagnosis of asthma in adults remains a challenge in the real world, which results in both over- and under-diagnosis. A taskforce was set up by the European Respiratory Society to systematically review the literature on the diagnostic accuracy of tests used to diagnose asthma in adult patients and provide recommendations for clinical practice. The taskforce defined eight Population, Index, Comparator and Outcome questions that were assessed using the Grading of Recommendations, Assessment, Development and Evaluation approach. The taskforce utilised the outcomes to develop an evidence-based diagnostic algorithm, with recommendations for a pragmatic guideline for everyday practice that was directed by real-life patient experiences. The taskforce supports the initial use of spirometry followed by bronchodilator reversibility testing (if airway obstruction is present). If initial spirometry fails to show obstruction, further tests should be performed in the following order: exhaled nitric oxide fraction, peak expiratory flow variability, or, in secondary care, bronchial challenge. We present the thresholds for each test that are compatible with a diagnosis of asthma in the presence of current symptoms. The taskforce reinforces spirometry as a priority and recognises the value of measuring blood eosinophils and serum immunoglobulin E to phenotype the patient. Measuring gas trapping by body plethysmography in patients with preserved forced expiratory volume in 1 s/forced vital capacity ratio deserves further attention. The taskforce draws attention to the difficulty of making a correct diagnosis in patients already receiving inhaled corticosteroids; the comorbidities that may obscure diagnosis; the importance of phenotyping; and the necessity of considering the patient experience in the diagnostic process.
- Published
- 2022
27. ERS statement:A core outcome set for clinical trials evaluating the management of COPD exacerbations
- Author
-
Mathioudakis, Alexander G., Abroug, Fekri, Agusti, Alvar, Ananth, Sachin, Bakke, Per, Bartziokas, Konstantinos, Beghe, Bianca, Bikov, Andras, Bradbury, Thomas, Brusselle, Guy, Cadus, Cordula, Coleman, Courtney, Contoli, Marco, Corlateanu, Alexandru, Corlateanu, Olga, Criner, Gerard J., Csoma, Balazs, Emelyanov, Alexander, Faner, Rosa, Romero, Gustavo Fernandez, Hammouda, Zeineb, Horváth, Peter, Garcia, Arturo Huerta, Jacobs, Michael, Jenkins, Christine, Joos, Guy, Kharevich, Olga, Kostikas, Konstantinos, Lapteva, Elena, Lazar, Zsofia, Leuppi, Joerg D., Liddle, Carol, Linnell, John, López-Giraldo, Alejandra, McDonald, Vanessa M., Nielsen, Rune, Papi, Alberto, Saraiva, Isabel, Sergeeva, Galina, Sioutkou, Agni, Sivapalan, Pradeesh, Stovold, Elizabeth, Wang, Hao, Wen, Fuqiang, Yorke, Janelle, Williamson, Paula R., Vestbo, Jørgen, Jensen, Jens Ulrik, Mathioudakis, Alexander G., Abroug, Fekri, Agusti, Alvar, Ananth, Sachin, Bakke, Per, Bartziokas, Konstantinos, Beghe, Bianca, Bikov, Andras, Bradbury, Thomas, Brusselle, Guy, Cadus, Cordula, Coleman, Courtney, Contoli, Marco, Corlateanu, Alexandru, Corlateanu, Olga, Criner, Gerard J., Csoma, Balazs, Emelyanov, Alexander, Faner, Rosa, Romero, Gustavo Fernandez, Hammouda, Zeineb, Horváth, Peter, Garcia, Arturo Huerta, Jacobs, Michael, Jenkins, Christine, Joos, Guy, Kharevich, Olga, Kostikas, Konstantinos, Lapteva, Elena, Lazar, Zsofia, Leuppi, Joerg D., Liddle, Carol, Linnell, John, López-Giraldo, Alejandra, McDonald, Vanessa M., Nielsen, Rune, Papi, Alberto, Saraiva, Isabel, Sergeeva, Galina, Sioutkou, Agni, Sivapalan, Pradeesh, Stovold, Elizabeth, Wang, Hao, Wen, Fuqiang, Yorke, Janelle, Williamson, Paula R., Vestbo, Jørgen, and Jensen, Jens Ulrik
- Abstract
Clinical trials evaluating the management of acute exacerbations of COPD assess heterogeneous outcomes, often omitting those that are clinically relevant or more important to patients. We have developed a core outcome set, a consensus-based minimum set of important outcomes that we recommend are evaluated in all future clinical trials on exacerbations management, to improve their quality and comparability. COPD exacerbations outcomes were identified through methodological systematic reviews and qualitative interviews with 86 patients from 11 countries globally. The most critical outcomes were prioritised for inclusion in the core outcome set through a two-round Delphi survey completed by 1063 participants (256 patients, 488 health professionals and 319 clinical academics) from 88 countries in five continents. Two global, multi-stakeholder, virtual consensus meetings were conducted to 1) finalise the core outcome set and 2) prioritise a single measurement instrument to be used for evaluating each of the prioritised outcomes. Consensus was informed by rigorous methodological systematic reviews. The views of patients with COPD were accounted for at all stages of the project. Survival, treatment success, breathlessness, quality of life, activities of daily living, the need for a higher level of care, arterial blood gases, disease progression, future exacerbations and hospital admissions, treatment safety and adherence were all included in the core outcome set. Focused methodological research was recommended to further validate and optimise some of the selected measurement instruments. The panel did not consider the prioritised set of outcomes and associated measurement instruments to be burdensome for patients and health professionals to use.
- Published
- 2022
28. European Respiratory Society guidelines for the diagnosis of asthma in adults
- Author
-
Louis, Renaud, primary, Satia, Imran, additional, Ojanguren, Inigo, additional, Schleich, Florence, additional, Bonini, Matteo, additional, Tonia, Thomy, additional, Rigau, David, additional, ten Brinke, Anne, additional, Buhl, Roland, additional, Loukides, Stelios, additional, Kocks, Janwillem W. H., additional, Boulet, Louis-Philippe, additional, Bourdin, Arnaud, additional, Coleman, Courtney, additional, Needham, Karen, additional, Thomas, Mike, additional, Idzko, Marco, additional, Papi, Alberto, additional, Porsbjerg, Celeste, additional, Schuermans, Daniel, additional, Soriano, Joan B., additional, and Usmani, Omar S., additional
- Published
- 2022
- Full Text
- View/download PDF
29. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
- Author
-
Mathioudakis, Alexander G., primary, Abroug, Fekri, additional, Agusti, Alvar, additional, Ananth, Sachin, additional, Bakke, Per, additional, Bartziokas, Konstantinos, additional, Beghe, Bianca, additional, Bikov, Andras, additional, Bradbury, Thomas, additional, Brusselle, Guy, additional, Cadus, Cordula, additional, Coleman, Courtney, additional, Contoli, Marco, additional, Corlateanu, Alexandru, additional, Corlateanu, Olga, additional, Criner, Gerard J., additional, Csoma, Balazs, additional, Emelyanov, Alexander, additional, Faner, Rosa, additional, Fernandez Romero, Gustavo, additional, Hammouda, Zeineb, additional, Horváth, Peter, additional, Huerta Garcia, Arturo, additional, Jacobs, Michael, additional, Jenkins, Christine, additional, Joos, Guy, additional, Kharevich, Olga, additional, Kostikas, Konstantinos, additional, Lapteva, Elena, additional, Lazar, Zsofia, additional, Leuppi, Joerg D., additional, Liddle, Carol, additional, Linnell, John, additional, López-Giraldo, Alejandra, additional, McDonald, Vanessa M., additional, Nielsen, Rune, additional, Papi, Alberto, additional, Saraiva, Isabel, additional, Sergeeva, Galina, additional, Sioutkou, Agni, additional, Sivapalan, Pradeesh, additional, Stovold, Elizabeth, additional, Wang, Hao, additional, Wen, Fuqiang, additional, Yorke, Janelle, additional, Williamson, Paula R., additional, Vestbo, Jørgen, additional, and Jensen, Jens-Ulrik, additional
- Published
- 2021
- Full Text
- View/download PDF
30. 3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD
- Author
-
Porsbjerg, Celeste, primary, Maitland-van der Zee, Anke H., additional, Brusselle, Guy, additional, Canonica, Giorgio Walter, additional, Agusti, Alvar, additional, Faner, Rosa, additional, Vogelmeier, Claus F., additional, Nawijn, Martijn, additional, van den Berge, Maarten, additional, Rusconi, Franca, additional, Pilette, Charles, additional, Ramiconi, Valeria, additional, Coleman, Courtney, additional, Chaudhuri, Rekha, additional, Chung, Kian Fan, additional, Wedzicha, Jadwiga, additional, Saglani, Sejla, additional, Van der Schee, Marc P., additional, Heaney, Liam, additional, Bourdin, Arnaud, additional, Roberts, Graham, additional, Djukanovic, Ratko, additional, Kuna, Piotr, additional, Kupczyk, Maciej, additional, Axmann, Judith, additional, Staudinger, Heribert, additional, Clarke, Graham W., additional, Dahlen, Sven Erik, additional, and Brightling, Chris, additional
- Published
- 2021
- Full Text
- View/download PDF
31. Family planning, pregnancy and birth in women with lung conditions: a worldwide survey
- Author
-
Williams, Clare, primary, Johnson, Barbara, additional, Middleton, Peter G., additional, Backer, Vibeke, additional, Gibson, Peter G., additional, Hollis, Gill, additional, and Coleman, Courtney, additional
- Published
- 2021
- Full Text
- View/download PDF
32. Rethinking COPD Exacerbations: a global patient perspective
- Author
-
Mwasuku, Chris, primary, Krassowska, Karolina, additional, Coleman, Courtney, additional, Powell, Pippa, additional, and Bafadhel, Mona, additional
- Published
- 2021
- Full Text
- View/download PDF
33. Poe's Pendulum
- Author
-
Borrelli, Robert L., Coleman, Courtney S., and Hobson, Dana D.
- Published
- 1985
- Full Text
- View/download PDF
34. Computers, Lies, and the Fishing Season
- Author
-
Borrelli, Robert L. and Coleman, Courtney S.
- Published
- 1994
- Full Text
- View/download PDF
35. A Certain Class of Integral Curves in 3-Space
- Author
-
Coleman, Courtney
- Published
- 1959
- Full Text
- View/download PDF
36. Balancing treatment and side-effects in severe asthma: a patient and professional perspective
- Author
-
Semple, Brenda, primary, Porsbjerg, Celeste, additional, and Coleman, Courtney, additional
- Published
- 2021
- Full Text
- View/download PDF
37. 3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
- Author
-
UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de l'allergie, UCL - (SLuc) Service de pneumologie, Porsbjerg, Celeste, Maitland-van der Zee, Anke H, Brusselle, Guy, Canonica, Giorgio Walter, Agusti, Alvar, Faner, Rosa, Vogelmeier, Claus F, Nawijn, Martijn, van den Berge, Maarten, Rusconi, Franca, Pilette, Charles, Ramiconi, Valeria, Coleman, Courtney, Chaudhuri, Rekha, Chung, Kian Fan, Wedzicha, Jadwiga, Saglani, Sejla, Van der Schee, Marc P, Heaney, Liam, Bourdin, Arnaud, Roberts, Graham, Djukanovic, Ratko, Kuna, Piotr, Kupczyk, Maceij, Axmann, Judith, Staudinger, Heribert, Clarke, Graham W, Dahlen, Sven Erik, Brightling, Chris, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de l'allergie, UCL - (SLuc) Service de pneumologie, Porsbjerg, Celeste, Maitland-van der Zee, Anke H, Brusselle, Guy, Canonica, Giorgio Walter, Agusti, Alvar, Faner, Rosa, Vogelmeier, Claus F, Nawijn, Martijn, van den Berge, Maarten, Rusconi, Franca, Pilette, Charles, Ramiconi, Valeria, Coleman, Courtney, Chaudhuri, Rekha, Chung, Kian Fan, Wedzicha, Jadwiga, Saglani, Sejla, Van der Schee, Marc P, Heaney, Liam, Bourdin, Arnaud, Roberts, Graham, Djukanovic, Ratko, Kuna, Piotr, Kupczyk, Maceij, Axmann, Judith, Staudinger, Heribert, Clarke, Graham W, Dahlen, Sven Erik, and Brightling, Chris
- Abstract
The 3TR (Taxonomy, Treatments, Targets and Remission) consortium is the largest IMI (Innovative Medicine Initiative) project ever started in the field of immune diseases (https://3tr-imi.eu/). 3TR is unique in bringing several medical specialties, encompassing respiratory medicine, rheumatology, neurology and gastroenterology, together, to study disease mechanisms across seven disease entities: asthma, COPD, systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, ulcerative colitis and Crohn's disease. [...]
- Published
- 2021
38. European Respiratory Society statement on thoracic ultrasound
- Author
-
Laursen, Christian B., Clive, Amelia, Hallifax, Rob, Pietersen, Pia Iben, Asciak, Rachelle, Davidsen, Jesper Rømhild, Bhatnagar, Rahul, Bedawi, Eihab O., Jacobsen, Niels, Coleman, Courtney, Edey, Anthony, Via, Gabriele, Volpicelli, Giovanni, Massard, Gilbert, Raimondi, Francesco, Evison, Matthew, Konge, Lars, Annema, Jouke, Rahman, Najib M., Maskell, Nick, Laursen, Christian B., Clive, Amelia, Hallifax, Rob, Pietersen, Pia Iben, Asciak, Rachelle, Davidsen, Jesper Rømhild, Bhatnagar, Rahul, Bedawi, Eihab O., Jacobsen, Niels, Coleman, Courtney, Edey, Anthony, Via, Gabriele, Volpicelli, Giovanni, Massard, Gilbert, Raimondi, Francesco, Evison, Matthew, Konge, Lars, Annema, Jouke, Rahman, Najib M., and Maskell, Nick
- Abstract
Thoracic ultrasound is increasingly considered to be an essential tool for the pulmonologist. It is used in diverse clinical scenarios, including as an adjunct to clinical decision making for diagnosis, a real-time guide to procedures and a predictor or measurement of treatment response. The aim of this European Respiratory Society task force was to produce a statement on thoracic ultrasound for pulmonologists using thoracic ultrasound within the field of respiratory medicine. The multidisciplinary panel performed a review of the literature, addressing major areas of thoracic ultrasound practice and application. The selected major areas include equipment and technique, assessment of the chest wall, parietal pleura, pleural effusion, pneumothorax, interstitial syndrome, lung consolidation, diaphragm assessment, intervention guidance, training and the patient perspective. Despite the growing evidence supporting the use of thoracic ultrasound, the published literature still contains a paucity of data in some important fields. Key research questions for each of the major areas were identified, which serve to facilitate future multicentre collaborations and research to further consolidate an evidence-based use of thoracic ultrasound, for the benefit of the many patients being exposed to clinicians using thoracic ultrasound.
- Published
- 2021
39. 3TR:A pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD
- Author
-
Porsbjerg, Celeste, Maitland-Van der Zee, Anke H., Brusselle, Guy, Canonica, Giorgio Walter, Agusti, Alvar, Faner, Rosa, Vogelmeier, Claus F., Nawijn, Martijn, van den Berge, Maarten, Rusconi, Franca, Pilette, Charles, Ramiconi, Valeria, Coleman, Courtney, Chaudhuri, Rekha, Chung, Kian Fan, Wedzicha, Jadwiga, Saglani, Sejla, van der Schee, Marc P., Heaney, Liam, Bourdin, Arnaud, Roberts, Graham, Djukanovic, Ratko, Kuna, Piotr, Kupczyk, Maciej, Axmann, Judith, Staudinger, Heribert, Clarke, Graham W., Dahlen, Sven Erik, Brightling, Chris, Porsbjerg, Celeste, Maitland-Van der Zee, Anke H., Brusselle, Guy, Canonica, Giorgio Walter, Agusti, Alvar, Faner, Rosa, Vogelmeier, Claus F., Nawijn, Martijn, van den Berge, Maarten, Rusconi, Franca, Pilette, Charles, Ramiconi, Valeria, Coleman, Courtney, Chaudhuri, Rekha, Chung, Kian Fan, Wedzicha, Jadwiga, Saglani, Sejla, van der Schee, Marc P., Heaney, Liam, Bourdin, Arnaud, Roberts, Graham, Djukanovic, Ratko, Kuna, Piotr, Kupczyk, Maciej, Axmann, Judith, Staudinger, Heribert, Clarke, Graham W., Dahlen, Sven Erik, and Brightling, Chris
- Published
- 2021
40. Balancing treatment and side-effects in severe asthma:A patient and professional perspective
- Author
-
Semple, Brenda, Porsbjerg, Celeste, Coleman, Courtney, Semple, Brenda, Porsbjerg, Celeste, and Coleman, Courtney
- Published
- 2021
41. European Respiratory Society Statement on Thoracic Ultrasound
- Author
-
Laursen, Christian B; https://orcid.org/0000-0001-6382-9906, Clive, Amelia, Hallifax, Rob, Pietersen, Pia Iben, Asciak, Rachelle, Davidsen, Jesper Rømhild; https://orcid.org/0000-0003-4128-4014, Bhatnagar, Rahul, Bedawi, Eihab O; https://orcid.org/0000-0001-9196-3934, Jacobsen, Niels, Coleman, Courtney, Edey, Anthony, Via, Gabriele, Volpicelli, Giovanni, Massard, Gilbert, Raimondi, Francesco, Evison, Matthew, Konge, Lars, Annema, Jouke, Rahman, Najib M, Maskell, Nick, Laursen, Christian B; https://orcid.org/0000-0001-6382-9906, Clive, Amelia, Hallifax, Rob, Pietersen, Pia Iben, Asciak, Rachelle, Davidsen, Jesper Rømhild; https://orcid.org/0000-0003-4128-4014, Bhatnagar, Rahul, Bedawi, Eihab O; https://orcid.org/0000-0001-9196-3934, Jacobsen, Niels, Coleman, Courtney, Edey, Anthony, Via, Gabriele, Volpicelli, Giovanni, Massard, Gilbert, Raimondi, Francesco, Evison, Matthew, Konge, Lars, Annema, Jouke, Rahman, Najib M, and Maskell, Nick
- Abstract
Thoracic ultrasound is increasingly considered to be an essential tool for the pulmonologist. It is used in diverse clinical scenarios, including as an adjunct to clinical decision making for diagnosis, a real-time guide to procedures, and a predictor or measurement of treatment response. The aim of this European Respiratory Society task force was to produce a statement on thoracic ultrasound for pulmonologists using thoracic ultrasound within the field of respiratory medicine. The multidisciplinary panel performed a review of the literature, addressing major areas of thoracic ultrasound practice and application. The selected major areas include equipment and technique, assessment of the chest wall, parietal pleura, pleural effusion, pneumothorax, interstitial syndrome, lung consolidation, diaphragm assessment, intervention guidance, training, and the patient perspective. Despite the growing evidence supporting the use of thoracic ultrasound, the published literature still contains a paucity of data in some important fields. Key research questions for each of the major areas were identified, which serve to facilitate future multi-centre collaborations and research to further consolidate an evidence-based use of thoracic ultrasound, for the benefit of the many patients being exposed to clinicians using thoracic ultrasound.
- Published
- 2021
42. Selective sweep at the Rpv3 locus during grapevine breeding for downy mildew resistance
- Author
-
Di Gaspero, Gabriele, Copetti, Dario, Coleman, Courtney, Castellarin, Simone Diego, Eibach, Rudolf, Kozma, Pál, Lacombe, Thierry, Gambetta, Gregory, Zvyagin, Andrey, Cindrić, Petar, Kovács, László, Morgante, Michele, and Testolin, Raffaele
- Published
- 2012
- Full Text
- View/download PDF
43. European Respiratory Society Statement on Thoracic Ultrasound
- Author
-
Laursen, Christian B., Clive, Amelia, Hallifax, Rob, Pietersen, Pia Iben, Asciak, Rachelle, Davidsen, Jesper Rømhild, Bhatnagar, Rahul, Bedawi, Eihab O., Jacobsen, Niels, Coleman, Courtney, Edey, Anthony, Via, Gabriele, Volpicelli, Giovanni, Massard, Gilbert, Raimondi, Francesco, Evison, Matthew, Konge, Lars, Annema, Jouke, Rahman, Najib M, Maskell, Nick, Laursen, Christian B., Clive, Amelia, Hallifax, Rob, Pietersen, Pia Iben, Asciak, Rachelle, Davidsen, Jesper Rømhild, Bhatnagar, Rahul, Bedawi, Eihab O., Jacobsen, Niels, Coleman, Courtney, Edey, Anthony, Via, Gabriele, Volpicelli, Giovanni, Massard, Gilbert, Raimondi, Francesco, Evison, Matthew, Konge, Lars, Annema, Jouke, Rahman, Najib M, and Maskell, Nick
- Abstract
Thoracic ultrasound is increasingly considered to be an essential tool for the pulmonologist. It is used in diverse clinical scenarios, including as an adjunct to clinical decision making for diagnosis, a real-time guide to procedures, and a predictor or measurement of treatment response. The aim of this European Respiratory Society task force was to produce a statement on thoracic ultrasound for pulmonologists using thoracic ultrasound within the field of respiratory medicine. The multidisciplinary panel performed a review of the literature, addressing major areas of thoracic ultrasound practice and application. The selected major areas include equipment and technique, assessment of the chest wall, parietal pleura, pleural effusion, pneumothorax, interstitial syndrome, lung consolidation, diaphragm assessment, intervention guidance, training, and the patient perspective. Despite the growing evidence supporting the use of thoracic ultrasound, the published literature still contains a paucity of data in some important fields. Key research questions for each of the major areas were identified, which serve to facilitate future multi-centre collaborations and research to further consolidate an evidence-based use of thoracic ultrasound, for the benefit of the many patients being exposed to clinicians using thoracic ultrasound.
- Published
- 2020
44. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease:the COS-AECOPD ERS Task Force study protocol
- Author
-
Mathioudakis, Alexander G, Abroug, Fekri, Agusti, Alvar, Bakke, Per, Bartziokas, Konstantinos, Beghe, Bianca, Bikov, Andras, Bradbury, Thomas, Brusselle, Guy, Cadus, Cordula, Coleman, Courtney, Contoli, Marco, Corlateanu, Alexandru, Corlateanu, Olga, Criner, Gerard, Csoma, Balazs, Emelyanov, Alexander, Faner, Rosa, Romero, Gustavo Fernandez, Hammouda, Zeineb, Horváth, Peter, Huerta, Arturo Garcia, Jacobs, Michael, Jenkins, Christine, Joos, Guy, Kharevich, Olga, Kostikas, Konstantinos, Lapteva, Elena, Lazar, Zsofia, Leuppi, Joerg D, Liddle, Carol, López-Giraldo, Alejandra, McDonald, Vanessa M, Nielsen, Rune, Papi, Alberto, Saraiva, Isabel, Sergeeva, Galina, Sioutkou, Agni, Sivapalan, Pradeesh, Stovold, Elizabeth, Wang, Hao, Wen, Fuqiang, Yorke, Janelle, Williamson, Paula R, Vestbo, Jørgen, Jensen, Jens-Ulrik, Mathioudakis, Alexander G, Abroug, Fekri, Agusti, Alvar, Bakke, Per, Bartziokas, Konstantinos, Beghe, Bianca, Bikov, Andras, Bradbury, Thomas, Brusselle, Guy, Cadus, Cordula, Coleman, Courtney, Contoli, Marco, Corlateanu, Alexandru, Corlateanu, Olga, Criner, Gerard, Csoma, Balazs, Emelyanov, Alexander, Faner, Rosa, Romero, Gustavo Fernandez, Hammouda, Zeineb, Horváth, Peter, Huerta, Arturo Garcia, Jacobs, Michael, Jenkins, Christine, Joos, Guy, Kharevich, Olga, Kostikas, Konstantinos, Lapteva, Elena, Lazar, Zsofia, Leuppi, Joerg D, Liddle, Carol, López-Giraldo, Alejandra, McDonald, Vanessa M, Nielsen, Rune, Papi, Alberto, Saraiva, Isabel, Sergeeva, Galina, Sioutkou, Agni, Sivapalan, Pradeesh, Stovold, Elizabeth, Wang, Hao, Wen, Fuqiang, Yorke, Janelle, Williamson, Paula R, Vestbo, Jørgen, and Jensen, Jens-Ulrik
- Abstract
Randomised controlled trials (RCTs) on the management of COPD exacerbations evaluate heterogeneous outcomes, often omitting those that are clinically important and patient relevant. This limits their usability and comparability. A core outcome set (COS) is a consensus-based minimum set of clinically important outcomes that should be evaluated in all RCTs in specific areas of health care. We present the study protocol of the COS-AECOPD ERS Task Force, aiming to develop a COS for COPD exacerbation management, that could remedy these limitations. For the development of this COS we follow standard methodology recommended by the COMET initiative. A comprehensive list of outcomes is assembled through a methodological systematic review of the outcomes reported in relevant RCTs. Qualitative research with patients with COPD will also be conducted, aiming to identify additional outcomes that may be important to patients, but are not currently addressed in clinical research studies. Prioritisation of the core outcomes will be facilitated through an extensive, multi-stakeholder Delphi survey with a global reach. Selection will be finalised in an international, multi-stakeholder meeting. For every core outcome, we will recommend a specific measurement instrument and standardised time points for evaluation. Selection of instruments will be based on evidence-informed consensus. Our work will improve the quality, usability and comparability of future RCTs on the management of COPD exacerbations and, ultimately, the care of patients with COPD. Multi-stakeholder engagement and societal support by the European Respiratory Society will raise awareness and promote implementation of the COS.
- Published
- 2020
45. ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases
- Author
-
Middleton, Peter G, Gade, Elisabeth J, Aguilera, Cristina, MacKillop, Lucy, Button, Brenda M, Coleman, Courtney, Johnson, Barbara, Albrechtsen, Charlotte, Edenborough, Frank, Rigau, David, Gibson, Peter G, Backer, Vibeke, Middleton, Peter G, Gade, Elisabeth J, Aguilera, Cristina, MacKillop, Lucy, Button, Brenda M, Coleman, Courtney, Johnson, Barbara, Albrechtsen, Charlotte, Edenborough, Frank, Rigau, David, Gibson, Peter G, and Backer, Vibeke
- Abstract
This European Respiratory Society/Thoracic Society of Australia and New Zealand statement outlines a review of the literature and expert opinion concerning the management of reproduction and pregnancy in women with airways diseases: asthma, cystic fibrosis (CF) and non-CF bronchiectasis. Many women with these diseases are now living into reproductive age, with some developing moderate-to-severe impairment of lung function in early adulthood. The statement covers aspects of fertility, management during pregnancy, effects of drugs, issues during delivery and the post-partum period, and patients' views about family planning, pregnancy and parenthood. The statement summarises current knowledge and proposes topics for future research, but does not make specific clinical recommendations.
- Published
- 2020
46. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
- Author
-
Mathioudakis, Alexander G., Abroug, Fekri, Agusti, Alvar, Bakke, Per, Bartziokas, Konstantinos, Beghe, Bianca, Bikov, Andras, Bradbury, Thomas, Brusselle, Guy, Cadus, Cordula, Coleman, Courtney, Contoli, Marco, Corlateanu, Alexandru, Corlateanu, Olga, Criner, Gerard, Csoma, Balazs, Emelyanov, Alexander, Faner, Rosa, Romero, Gustavo Fernandez, Hammouda, Zeineb, Horvath, Peter, Huerta, Arturo Garcia, Jacobs, Michael, Jenkins, Christine, Joos, Guy, Kharevich, Olga, Kostikas, Konstantinos, Lapteva, Elena, Lazar, Zsofia, Leuppi, Joerg D., Liddle, Carol, Lopez-Giraldo, Alejandra, McDonald, Vanessa M., Nielsen, Rune, Papi, Alberto, Saraiva, Isabel, Sergeeva, Galina, Sioutkou, Agni, Sivapalan, Pradeesh, Stovold, Elizabeth, Wang, Hao, Wen, Fuqiang, Yorke, Janelle, Williamson, Paula R., Vestbo, Jorgen, Jensen, Jens-Ulrik, Mathioudakis, Alexander G., Abroug, Fekri, Agusti, Alvar, Bakke, Per, Bartziokas, Konstantinos, Beghe, Bianca, Bikov, Andras, Bradbury, Thomas, Brusselle, Guy, Cadus, Cordula, Coleman, Courtney, Contoli, Marco, Corlateanu, Alexandru, Corlateanu, Olga, Criner, Gerard, Csoma, Balazs, Emelyanov, Alexander, Faner, Rosa, Romero, Gustavo Fernandez, Hammouda, Zeineb, Horvath, Peter, Huerta, Arturo Garcia, Jacobs, Michael, Jenkins, Christine, Joos, Guy, Kharevich, Olga, Kostikas, Konstantinos, Lapteva, Elena, Lazar, Zsofia, Leuppi, Joerg D., Liddle, Carol, Lopez-Giraldo, Alejandra, McDonald, Vanessa M., Nielsen, Rune, Papi, Alberto, Saraiva, Isabel, Sergeeva, Galina, Sioutkou, Agni, Sivapalan, Pradeesh, Stovold, Elizabeth, Wang, Hao, Wen, Fuqiang, Yorke, Janelle, Williamson, Paula R., Vestbo, Jorgen, and Jensen, Jens-Ulrik
- Published
- 2020
47. Improving spirometry testing by understanding patient preferences
- Author
-
Johnson, Barbara, primary, Steenbruggen, Irene, additional, Graham, Brian L., additional, and Coleman, Courtney, additional
- Published
- 2020
- Full Text
- View/download PDF
48. European Respiratory Society statement on thoracic ultrasound
- Author
-
Laursen, Christian B., primary, Clive, Amelia, additional, Hallifax, Rob, additional, Pietersen, Pia Iben, additional, Asciak, Rachelle, additional, Davidsen, Jesper Rømhild, additional, Bhatnagar, Rahul, additional, Bedawi, Eihab O., additional, Jacobsen, Niels, additional, Coleman, Courtney, additional, Edey, Anthony, additional, Via, Gabriele, additional, Volpicelli, Giovanni, additional, Massard, Gilbert, additional, Raimondi, Francesco, additional, Evison, Matthew, additional, Konge, Lars, additional, Annema, Jouke, additional, Rahman, Najib M., additional, and Maskell, Nick, additional
- Published
- 2020
- Full Text
- View/download PDF
49. A Novel Grape Downy Mildew Resistance Locus fromVitis rupestris
- Author
-
Bhattarai, Gaurab, primary, Fennell, Anne, additional, Londo, Jason P., additional, Coleman, Courtney, additional, and Kovacs, Laszlo G., additional
- Published
- 2020
- Full Text
- View/download PDF
50. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
- Author
-
Mathioudakis, Alexander G., primary, Abroug, Fekri, additional, Agusti, Alvar, additional, Bakke, Per, additional, Bartziokas, Konstantinos, additional, Beghe, Bianca, additional, Bikov, Andras, additional, Bradbury, Thomas, additional, Brusselle, Guy, additional, Cadus, Cordula, additional, Coleman, Courtney, additional, Contoli, Marco, additional, Corlateanu, Alexandru, additional, Corlateanu, Olga, additional, Criner, Gerard, additional, Csoma, Balazs, additional, Emelyanov, Alexander, additional, Faner, Rosa, additional, Romero, Gustavo Fernandez, additional, Hammouda, Zeineb, additional, Horváth, Peter, additional, Huerta, Arturo Garcia, additional, Jacobs, Michael, additional, Jenkins, Christine, additional, Joos, Guy, additional, Kharevich, Olga, additional, Kostikas, Konstantinos, additional, Lapteva, Elena, additional, Lazar, Zsofia, additional, Leuppi, Joerg D., additional, Liddle, Carol, additional, López-Giraldo, Alejandra, additional, McDonald, Vanessa M., additional, Nielsen, Rune, additional, Papi, Alberto, additional, Saraiva, Isabel, additional, Sergeeva, Galina, additional, Sioutkou, Agni, additional, Sivapalan, Pradeesh, additional, Stovold, Elizabeth, additional, Wang, Hao, additional, Wen, Fuqiang, additional, Yorke, Janelle, additional, Williamson, Paula R., additional, Vestbo, Jørgen, additional, and Jensen, Jens-Ulrik, additional
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.